The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Oncolytics Biotech, Inc. (NASDAQ: ONCY) closed at $0.91 down -4.06% from its previous closing price of $0.95. In other words, the price has decreased by -$4.06 from its previous closing price. On the day, 0.65 million shares were traded. ONCY stock price reached its highest trading level at $0.95 during the session, while it also had its lowest trading level at $0.85.
Ratios:
For a deeper understanding of Oncolytics Biotech, Inc.’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.99 and its Current Ratio is at 4.99. In the meantime, Its Debt-to-Equity ratio is 0.06 whereas as Long-Term Debt/Eq ratio is at 0.05.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Maxim Group on October 06, 2022, initiated with a Buy rating and assigned the stock a target price of $3.
On February 17, 2021, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $15.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ONCY now has a Market Capitalization of 69963112 and an Enterprise Value of 49310348.
Stock Price History:
Over the past 52 weeks, ONCY has reached a high of $2.49, while it has fallen to a 52-week low of $0.88. The 50-Day Moving Average of the stock is -11.23%, while the 200-Day Moving Average is calculated to be -22.24%.
Shares Statistics:
For the past three months, ONCY has traded an average of 182.19K shares per day and 280770 over the past ten days. A total of 74.42M shares are outstanding, with a floating share count of 73.88M. Insiders hold about 4.04% of the company’s shares, while institutions hold 2.15% stake in the company. Shares short for ONCY as of 1722384000 were 645124 with a Short Ratio of 3.55, compared to 1719532800 on 665298. Therefore, it implies a Short% of Shares Outstanding of 645124 and a Short% of Float of 0.89.
Earnings Estimates
The market rating of Oncolytics Biotech, Inc. (ONCY) is currently shaped by the ongoing analysis conducted by 5.0 analysts closely monitoring its performance.The consensus estimate for the next quarter is -$0.07, with high estimates of -$0.06 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.26 and -$0.32 for the fiscal current year, implying an average EPS of -$0.29. EPS for the following year is -$0.31, with 5.0 analysts recommending between -$0.23 and -$0.36.
